NCT05514132 2026-03-09
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT06795412 2026-03-06
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Pyxis Oncology, Inc
Phase 1/2 Recruiting
NCT05701527 2026-02-05
A Study of EBC-129 in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Recruiting
NCT06929260 2026-01-22
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
AstraZeneca
Phase 1 Terminated
NCT05508334 2025-12-22
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Completed